Nanomagnetic isolation and sensing for mobile HIV-1 self-testing
用于移动 HIV-1 自检的纳米磁隔离和传感
基本信息
- 批准号:10002182
- 负责人:
- 金额:$ 46.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-26 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcquired Immunodeficiency SyndromeAdvanced DevelopmentAntibodiesAntigensBenchmarkingBiological MarkersBloodBlood VolumeCar PhoneClinicalComplexCoupledData AnalysesDetectionDevelopmentDevicesDiagnosticDiseaseDisease ProgressionDisease remissionDrug resistanceEarly DiagnosisElementsEquipmentEvaluationFingersFutureGeometryGoalsGoldHIVHIV-1HandHome environmentHumanLabelLaboratoriesLiquid substanceMagnetismMethodsModelingModificationMonitorNucleic AcidsOligonucleotidesOutcomePatientsPerformancePlasmaPreparationProceduresReactionRecurrenceResearchRiskSamplingSpecificitySpecimenSystemT-LymphocyteTechnologyTestingTimeVariantVesicleViralViral Load resultViremiaVirusantiretroviral therapybaseclinically relevantcommercializationcostdesigndrug efficacygraphenehandheld mobile deviceindividual patientinnovationinnovative technologiesinstrumentationmanufacturabilitynanomagneticnanoporenanoscalenanosensorsnoninvasive diagnosisnovelnucleic acid detectionpoint of careportabilityprototypesensortissue culturetransmission processtreatment strategyviral detectionviral rebound
项目摘要
Project Summary
Antiretroviral treatment (ART) requires close monitoring of HIV-1 plasma viremia to confirm viral
suppression, and to identify viral rebound due to nonadherence or drug resistance to initiate
timely treatment modification. Thus, frequent efficient monitoring for HIV in blood via methods
that are accessible for home self-testing is a critical need. Current self-detection strategies only
detect antibody, and existing virus detection methods require extensive equipment and
expertise (RNA) and/or have limited sensitivity (antigen). We aim to fill this gap with the
development of an inexpensive, automated, portable system that will detect new or recurrent
plasma viremia with high specificity and sufficient sensitivity for self-monitoring in these
contexts. The ultimate goal of this project is to develop a platform technology for low-cost (<
$2/test) point-of-care nucleic acid diagnostics for use on crude human samples (plasma) to
quantitate viral RNA with a detection limit < 10 virus / sample (equivalent to a clinically-relevant
threshold of 1000 copy/ml on 10 ul finger prick blood). The method will be simple to perform and
will not require complex amplification procedures such as PCR. The novelty of our approach is
to combine two innovative technologies invented by our team - one for target separation and
concentration suitable for any starting blood volume, and one for label-free nucleic acid
detection without amplification – into an integrated device. The goal of our R66 is to design a
laboratory-based integrated system to demonstrate quantitation of HIV viral load on tissue
culture derived virus spiked into healthy plasma. The goals of our R33 are advanced
development of our technology into a fully-automated handheld mobile-phone based device to
be used by non-microfluidic experts, and evaluation using banked clinical samples through
partnership with Penn's Center for AIDS Research.
项目摘要
抗逆转录病毒治疗(ART)需要密切监测HIV-1血浆病毒血症,
抑制,并确定由于不依从或耐药性引起的病毒反弹,以启动
及时调整治疗方案。因此,经常有效地监测血液中的艾滋病毒,
可用于家庭自我检测的设备是一个关键需求。仅限当前的自我检测策略
检测抗体,现有的病毒检测方法需要大量的设备,
专业知识(RNA)和/或具有有限的敏感性(抗原)。我们的目标是填补这一空白,
开发一种廉价、自动化、便携式系统,
血浆病毒血症具有高特异性和足够的灵敏度,可用于这些患者的自我监测。
contexts.本项目的最终目标是开发一种低成本(<
2美元/检测)用于人类粗样品(血浆)的即时核酸诊断,
定量病毒RNA,检测限< 10个病毒/样品(相当于临床相关的
在10 μ l手指刺血上1000拷贝/ml的阈值)。该方法将易于执行,
不需要复杂的扩增程序如PCR。我们方法的新奇在于
将我们团队发明的两项创新技术联合收割机结合起来-一项用于目标分离,
一种浓度适用于任何起始血液体积,一种浓度适用于无标记核酸
无需放大即可检测-集成到集成设备中。我们的R66的目标是设计一个
用于演示组织上HIV病毒载量定量的基于实验室的集成系统
将培养物衍生的病毒掺入健康血浆中。我们的R33的目标是先进的
我们的技术发展成为一个完全自动化的手持移动电话为基础的设备,
由非微流体专家使用,并通过使用库存临床样本进行评估,
与宾夕法尼亚大学艾滋病研究中心合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Aaron Issadore其他文献
David Aaron Issadore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Aaron Issadore', 18)}}的其他基金
High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics
用于超灵敏多重诊断的高通量数字液滴 ELISA
- 批准号:
9889673 - 财政年份:2020
- 资助金额:
$ 46.27万 - 项目类别:
High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics
用于超灵敏多重诊断的高通量数字液滴 ELISA
- 批准号:
10359798 - 财政年份:2020
- 资助金额:
$ 46.27万 - 项目类别:
Nanomagnetic isolation and sensing for mobile HIV-1 self-testing
用于移动 HIV-1 自检的纳米磁隔离和传感
- 批准号:
10663625 - 财政年份:2019
- 资助金额:
$ 46.27万 - 项目类别:
Nanomagnetic isolation and sensing for mobile HIV-1 self-testing
用于移动 HIV-1 自检的纳米磁隔离和传感
- 批准号:
10224709 - 财政年份:2019
- 资助金额:
$ 46.27万 - 项目类别:
A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles
使用脑源性细胞外囊泡表征创伤性脑损伤的纳米磁性平台技术
- 批准号:
9788528 - 财政年份:2018
- 资助金额:
$ 46.27万 - 项目类别:
A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles
使用脑源性细胞外囊泡表征创伤性脑损伤的纳米磁性平台技术
- 批准号:
10261451 - 财政年份:2018
- 资助金额:
$ 46.27万 - 项目类别:
A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles
使用脑源性细胞外囊泡表征创伤性脑损伤的纳米磁性平台技术
- 批准号:
10019696 - 财政年份:2018
- 资助金额:
$ 46.27万 - 项目类别:
Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip
使用基于磁性微孔的诊断芯片对循环肿瘤细胞进行快速无偏分离和原位 RNA 分析
- 批准号:
9277638 - 财政年份:2017
- 资助金额:
$ 46.27万 - 项目类别:
Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip
使用基于磁性微孔的诊断芯片对循环肿瘤细胞进行快速无偏分离和原位 RNA 分析
- 批准号:
9752954 - 财政年份:2017
- 资助金额:
$ 46.27万 - 项目类别:
A micro Hall chip for circulating microvesicle based cancer monitoring
用于基于循环微泡的癌症监测的微型霍尔芯片
- 批准号:
8733954 - 财政年份:2014
- 资助金额:
$ 46.27万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 46.27万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 46.27万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 46.27万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 46.27万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 46.27万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 46.27万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 46.27万 - 项目类别: